Celldex Therapeutics, Inc. · NASDAQ:CLDX
Commodore Capital LP reported a 5.00% stake in Celldex Therapeutics, Inc. (Schedule 13G)
Event Apr 3, 2025 · Filed Apr 10, 2025
Commodore Capital LP reported a 5.00% stake in Celldex Therapeutics, Inc., 3,350,000 shares, as a passive investor on Apr 3, 2025. Filed Apr 10, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 3,350,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| COMMODORE CAPITAL LP | 5.00% | 3,350,000 |
| Commodore Capital Master LP | 5.00% | 3,350,000 |
Source
Related
- Celldex Therapeutics, Inc.
- Commodore Capital LP
- Celldex Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · May 15, 2026
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026